Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Lymphocytes, Tumor-Infiltrating MeSH Descriptor Data 2025


MeSH Heading
Lymphocytes, Tumor-Infiltrating
Tree Number(s)
A11.118.637.555.567.650
A15.145.229.637.555.567.650
A15.382.490.555.567.650
Unique ID
D016246
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D016246
Annotation
subpopulations: coordinate with LYMPHOCYTE SUBSETS or specifics
Scope Note
Lymphocytes that show specificity for autologous tumor cells. Ex vivo isolation and culturing of TIL with interleukin-2, followed by reinfusion into the patient, is one form of adoptive immunotherapy of cancer.
Entry Term(s)
Tumor Infiltrating Lymphocyte
Tumor-Derived Activated Cell
Tumor-Derived Activated Cells
Tumor-Infiltrating Lymphocyte
Tumor-Infiltrating Lymphocytes
Previous Indexing
Lymphocytes (1976-1990)
T-Lymphocytes (1977-1990)
T-Lymphocytes, Cytotoxic (1984-1990)
See Also
Immunotherapy, Adoptive
Public MeSH Note
91
History Note
91
Date Established
1991/01/01
Date of Entry
1990/06/06
Revision Date
2020/05/27
Lymphocytes, Tumor-Infiltrating Preferred
Tumor-Derived Activated Cells Narrower
page delivered in 0.124s